Asa Rosenquist
Solna, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 21, 2025
Discovery of β-d-2'-deoxy-2'-dichlorouridine nucleotide prodrugs as potent inhibitors of hepatitis C virus replication.
Journal: Bioorganic & medicinal chemistry letters
Published: April 11, 2017
Synthesis of P1'-functionalized macrocyclic transition-state mimicking HIV-1 protease inhibitors encompassing a tertiary alcohol.
Journal: Journal of medicinal chemistry
Published: July 24, 2014
Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor.
Journal: Journal of medicinal chemistry
Published: January 23, 2014
Nucleotide prodrugs of 2'-deoxy-2'-spirooxetane ribonucleosides as novel inhibitors of the HCV NS5B polymerase.
Journal: Journal of medicinal chemistry
Published: December 19, 2013
Design and synthesis of P1-P3 macrocyclic tertiary-alcohol-comprising HIV-1 protease inhibitors.
Journal: Journal of medicinal chemistry
Published: October 29, 2013
Design and synthesis of HIV-1 protease inhibitors for a long-acting injectable drug application.
Journal: Bioorganic & medicinal chemistry letters
Published: September 26, 2012
Synthesis, X-ray analysis, and biological evaluation of a new class of stereopure lactam-based HIV-1 protease inhibitors.
Journal: Journal of medicinal chemistry
Published: March 02, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026